No Data
Sidoti Initiates Assertio(ASRT.US) With Hold Rating, Announces Target Price $3
Sidoti Remains a Hold on Assertio Therapeutics (ASRT)
Assertio Holdings, Inc. Grants Restricted Stock Units and Stock Options to New Chief Commercial Officer Mary Pietryga
Press Release: Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Express News | Assertio Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Assertio Therapeutics Announces Leadership Changes and Board Addition
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
